Literature DB >> 32775667

Venous Air Embolism: A Rare but Possible Complication During Retrograde Intrarenal Surgery-A Case Report and Review of Literature.

Kumar Prem1, Kumar Pankaj1, Jayati Saxena2, Somesh Janoria1.   

Abstract

Background: Venous air embolism (VAE) during various urologic surgeries such as transurethral resection of prostate, percutaneous nephrolithotomy (PCNL) and occasionally while performing air pyelogram during PCNL have been reported in the literature. Case Presentation: In this study, we present a case of 34 year-old gentleman who developed intraoperative VAE during retrograde intrarenal surgery (RIRS). The clinical suspicion and diagnosis were made by fall in end-tidal carbon dioxide and oxygen saturation, transient hypotension, and bradycardia. The patient was managed conservatively. The most important factor was timely detection and early management by the anesthetist.
Conclusion: To our knowledge, this is the first case of VAE reported during RIRS. For procedures such as RIRS complicating to VAE, a high index of suspicion and prompt management is required. Copyright 2020, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  retrograde intrarenal surgery; urologic surgery; venous air embolism

Year:  2020        PMID: 32775667      PMCID: PMC7383463          DOI: 10.1089/cren.2019.0075

Source DB:  PubMed          Journal:  J Endourol Case Rep        ISSN: 2379-9889


  3 in total

1.  Volume of air in a lethal venous air embolism.

Authors:  T J Toung; M I Rossberg; G M Hutchins
Journal:  Anesthesiology       Date:  2001-02       Impact factor: 7.892

2.  Fatal gas embolism during ureteroscopic holmium: yttrium-aluminium-garnet laser lithotripsy under spinal anesthesia - a case report.

Authors:  Chung-Pei Chang; Chuang-Chyun Liou; Ya-Ling Yang; Maw-Sheng Sun
Journal:  Minim Invasive Ther Allied Technol       Date:  2008       Impact factor: 2.442

3.  Pyelovenous backflow. Facts, fallacies and significance.

Authors:  F A Lopez; M Dalinka; J G Doboy
Journal:  Urology       Date:  1973-12       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.